Envista (NYSE: NVST) today announced it appointed three new leaders to the chief financial officer, Nobel Biocare president and Ormco president roles.
The Brea, California-based dental company appointed Eric Hammes as CFO, Stefan Nilsson as president of Nobel Biocare and Veronica Acurio as president of Ormco, each effective in the coming weeks.
Hammes will take over as CFO on August 8. He succeeds Stephen Keller who served as interim principal financial officer since September 2023. He has over 25 years of operational and financial leadership experience.
Prior to joining Envista, Hammes was VP of corporate financial planning and analysis at Rockwell Automation. He has also held numerous leadership roles at 3M and 3M Health Care, including senior VP controller and chief accounting officer, CFO of 3M Health Care, and director of finance for the orthodontics products division.
“We are proud to have Eric join us as CFO. He is a transformational leader with a strong track record of delivering continuous improvement and increasing shareholder value. He has directly relevant experience in both dental and health care as well as multi-segment global businesses. Eric is well positioned to help our leadership team accelerate Envista’s growth, expand our margins, and further advance our portfolio,” CEO Paul Keel said in a news release.
Nilsson’s appointment as president of Nobel Biocare took effect on July 15. Most recently, he was CEO of Colosseum Dental Group. Nilsson has also served as CEO of GrandVision Brazil and held numerous leadership roles at Nestle in a variety of operations, including marketing and general management roles.
“It is an honor to join Envista as President of Nobel Biocare, the premier brand in implants. Nobel is the pioneer of implant innovation and well-positioned to lead the future of this specialty. As a customer, I saw firsthand the strength of Nobel Biocare’s innovation, their best-in-class clinical solutions, and the vibrant community of clinicians around the brand. I am delighted to be working with the Nobel team and our clinical partners to further advance our business and the future of implant dentistry,” Nilsson said.
Acurio joins the company from Solventum, 3M’s Health Care business spinoff, where she was president of 3M’s Medical Solutions division. She will take on the role of president of orthodontics on August 2.
Prior to leading 3M’s $5 billion Medical Solutions division, Acurio held various commercial, operational, and business leadership roles within 3M.
“We are delighted to welcome Veronica to Envista. She is an accomplished leader with a proven track record of leading dental and medical businesses all around the world. Her passionate focus on customers and innovation ideally positions Veronica to further advance Ormco as the partner of choice for orthodontic specialists,” Keel said.
